EssilorLuxottica Société Anonyme (ENXTPA:EL) Could Be 34% Undervalued After New Buyback Plan
EssilorLuxottica Société anonyme (ENXTPA:EL) has announced a new share buyback program authorizing the repurchase of up to five million shares, about 1.1% of its outstanding stock, which refocuses attention on capital allocation.
Set against this buyback announcement, EssilorLuxottica Société anonyme’s 1 day share price return of 2.44% contrasts with a weaker recent patch. The 30 day share price return is down 1.65%, and the year to date share price return is down 39.23%.
Spot opportunities alongside EssilorLuxottica Société anonyme by scanning our hand picked list of 615 high quality undiscovered gems that pairs solid fundamentals with under the radar share prices.For EssilorLuxottica Société anonyme, a 2.44% one-day bounce sits against a much weaker year so far. Is this buyback-driven rise a readout on the underlying business, or a short-term shift in sentiment that the valuation now needs to explain?
Most Popular Narrative: 33.5% Undervalued
EssilorLuxottica Société anonyme closed at €161.35, while the most followed narrative places fair value at about €242.65. This is a sizeable gap that this buyback now puts under the spotlight.
Investments in smart eyewear, AI-enabled vision solutions, and MedTech (Ray-Ban Meta, Oakley Meta, Nuance Audio, acquisition of Optegra Eye Clinics) capitalize on long-term demand for technologically advanced and personalized eye health platforms. These investments are seen as catalyzing product mix upgrades and higher ASPs, which are expected to benefit gross margin and future earnings.
Want to understand why this narrative supports a higher fair value for EssilorLuxottica Société anonyme? It focuses on the potential for faster revenue growth, wider margins, and a premium earnings multiple that many investors may not be considering yet.
Result: Fair Value of €242.65 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, EssilorLuxottica Société anonyme still faces pressure from rising competition in AI glasses and potential regulatory delays that could slow new MedTech and smart eyewear revenue streams.
Find out about the key risks to this EssilorLuxottica Société anonyme narrative.
Another View on EssilorLuxottica Société anonyme’s Valuation
The first narrative leans heavily on future earnings and cash flows for EssilorLuxottica Société anonyme. Yet on a simple earnings multiple, the picture is less clear. The current P/E of 29.7x is higher than the 25.9x industry average and the 24.4x fair ratio estimate, which points to less room for error.
If the market eventually moves closer to that fair ratio, today’s premium multiple could compress rather than expand. The question for you is whether EssilorLuxottica Société anonyme’s story is strong enough that the market keeps paying up for it, or if the risk sits more on the downside of that gap.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of optimism and concern around EssilorLuxottica Société anonyme, it makes sense to move quickly and review the data yourself so you are not relying on a single storyline. To weigh both sides of the debate in one place, start with the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond EssilorLuxottica Société anonyme?
Do not stop with just one stock story. The best portfolios usually come from comparing several strong ideas side by side using clear and consistent data.
- Target potential mispricing by scanning a focused group of quality stocks that trade below their estimated worth with the help of 265 high quality undervalued stocks.
- Strengthen your income stream by reviewing companies that pair higher yields with resilience in our hand picked set of 415 dividend fortresses.
- Limit downside shocks by concentrating on companies with cleaner finances and sturdier metrics using the curated list of solid balance sheet and fundamentals (427 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com